The store will not work correctly when cookies are disabled.
N,N-dimethyl-2-(6-(5-(trifluoromethyl)thiophen-2-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide
ID: ALA4531750
PubChem CID: 124176291
Max Phase: Preclinical
Molecular Formula: C16H14F3N3OS
Molecular Weight: 353.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)C(=O)Cn1ccc2ncc(-c3ccc(C(F)(F)F)s3)cc21
Standard InChI: InChI=1S/C16H14F3N3OS/c1-21(2)15(23)9-22-6-5-11-12(22)7-10(8-20-11)13-3-4-14(24-13)16(17,18)19/h3-8H,9H2,1-2H3
Standard InChI Key: LPFCXGVNLRXWCM-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
4.9513 -15.9434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9501 -16.7630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6582 -17.1719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6564 -15.5346 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3650 -15.9398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3698 -16.7585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1498 -17.0069 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6272 -16.3418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1421 -15.6824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4069 -17.7826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2072 -17.9479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4642 -18.7236 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7504 -17.3374 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9209 -19.3341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2645 -18.8888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2421 -17.1710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4944 -16.8395 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.9471 -17.4464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3551 -18.1544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1545 -17.9851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1344 -17.3603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8026 -16.6135 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.6536 -18.0210 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.3166 -17.3591 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
12 15 1 0
2 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 16 2 0
18 21 1 0
21 22 1 0
21 23 1 0
21 24 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 353.37 | Molecular Weight (Monoisotopic): 353.0810 | AlogP: 3.87 | #Rotatable Bonds: 3 |
Polar Surface Area: 38.13 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.06 | CX LogP: 3.02 | CX LogD: 3.02 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.72 | Np Likeness Score: -1.60 |
References
1. Chrovian CC, Soyode-Johnson A, Wall JL, Rech JC, Schoellerman J, Lord B, Coe KJ, Carruthers NI, Nguyen L, Jiang X, Koudriakova T, Balana B, Letavic MA.. (2019) 1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators., 10 (3): [PMID:30891123] [10.1021/acsmedchemlett.8b00542] |
2. Chrovian CC,Soyode-Johnson A,Stenne B,Pippel DJ,Schoellerman J,Lord B,Needham AS,Xia C,Coe KJ,Sepassi K,Schoetens F,Scott B,Nguyen L,Jiang X,Koudriakova T,Balana B,Letavic MA. (2020) Design, Synthesis, and Preclinical Evaluation of 3-Methyl-6-(5-thiophenyl)-1,3-dihydro-imidazo[4,5-b]pyridin-2-ones as Selective GluN2B Negative Allosteric Modulators for the Treatment of Mood Disorders., 63 (17): [PMID:32787105] [10.1021/acs.jmedchem.9b02113] |